Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Financial tracks

    Sage Kelly resigned as managing director and global head of healthcare investment banking at Jefferies & Co. Inc. Laurence Reid is resigning as CBO of Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY), effective Dec. 31. He …

    Published on 12/19/2014
  • FINANCIAL NEWS: Juno gains 46% in first trading day

    Juno Therapeutics Inc. (NASDAQ:JUNO) gained $11 (46%) to $35 on Friday, its first day of trading, after raising $264.6 million through the sale of 11 million shares at $24 in its IPO. The cancer immunotherapy developer …

    Published on 12/19/2014
  • FINANCIAL NEWS: Ascendis files for IPO

    Ascendis Pharma A/S (Hellerup, Denmark) filed to raise up to $86.3 million in an IPO on NASDAQ underwritten by BofA Merrill Lynch; Leerink; and Wells Fargo. On Monday, Ascendis reported interim Phase II data for its …

    Published on 12/18/2014
  • FINANCIAL NEWS: Avalanche double-dip would double up

    Ophthalmic gene therapy company Avalanche Biotechnologies Inc. (NASDAQ:AAVL) said it plans to raise up to $100 million in a follow-on underwritten by Jefferies; Cowen; Piper Jaffray; and William Blair. Avalanche gained…

    Published on 12/18/2014
  • FINANCIAL NEWS: Padlock raises $23M series A

    Padlock Therapeutics Inc. (Cambridge, Mass.) secured $23 million in a tranched series A round led by Atlas Venture. Johnson & Johnson Development Corp. (JJDC), MS Ventures, and Index Ventures also participated. Padlock …

    Published on 12/18/2014
  • FINANCIAL NEWS: $24M gift for allergy research at Stanford

    Silicon Valley entrepreneur Sean Parker pledged $24 million over the next two years to establish a research center at the Stanford University School of Medicine that aims to discover lasting cures for allergies. Parker …

    Published on 12/17/2014
  • FINANCIAL NEWS: Exact raises $103M in follow-on

    Exact Sciences Corp. (NASDAQ:EXAS) raised $103 million through the sale of 4 million shares at $25.75 in a follow-on underwritten by Jefferies and Baird. FDA approved Exact's Cologuard in August. The non-invasive DNA …

    Published on 12/16/2014
  • FINANCIAL NEWS: Juno upsizes proposed IPO

    Juno Therapeutics Inc. (Seattle, Wash.) amended its proposed IPO on NASDAQ and now plans to sell 9.3 million shares at $21-$23. At $22, Juno would raise $203.5 million and be valued at $1.7 billion. Last week, the …

    Published on 12/16/2014
  • FINANCIAL NEWS: Sequoia raising new fund

    Sequoia Capital declined to comment on news the VC firm is looking to raise an undisclosed amount for Sequoia Capital U.S. Venture Fund XV, according to an SEC filing from last week. Sequoia largely invests in the …

    Published on 12/16/2014
  • FINANCIAL NEWS: Alimera raises $50M from Deerfield

    DME play Alimera Sciences Inc. (NASDAQ:ALIM) closed a $50 million private placement with Deerfield Management. The firm and its affiliates agreed to acquire 8,292 non-voting series B shares at $6,030 on Nov. 26, and can…

    Published on 12/15/2014
  • FINANCIAL NEWS: Annexon raises $34M in series A-1

    Annexon Bioscience raised $34 million in a series A-1 round led by Novartis Venture Fund along with Satter Investment Management and Clarus Ventures. All were new investors. CEO Doug Love told BioCentury the round is "…

    Published on 12/15/2014
  • FINANCIAL NEWS: Back to the feeder: bluebird raises $225.3M in follow-on

    Gene therapy play bluebird bio Inc. (NASDAQ:BLUE) raised $225.3 million by pricing 2.7 million shares at $85 in its second follow-on of the year. BofA Merrill Lynch; Cowen; SunTrust; Wedbush; and Roth were underwriters.…

    Published on 12/15/2014
  • FINANCIAL NEWS: CIRM 2.0: New urgency for therapeutic development

    Ten years after California voters passed Proposition 71 on the promise that stem cell technology would produce new therapies, the board of the the California Institute for Regenerative Medicine (CIRM) last week …

    Published on 12/15/2014
  • FINANCIAL NEWS: Financial tracks

    HealthCare Royalty Partners has named Christopher White COO, effective Dec. 18. He was managing director and head of investment banking at Janney Montgomery Scott.Barclays hired Geoffrey Meacham as a managing director …

    Published on 12/12/2014
  • FINANCIAL NEWS: Flexion raises $85.7M in upsized follow-on

    Flexion Therapeutics Inc. (NASDAQ:FLXN) raised $85.7 million through the sale of 5 million shares at $17 in an upsized follow-on underwritten by BMO Capital Markets; RBC Capital Markets; Needham; Janney Montgomery Scott…

    Published on 12/12/2014
  • FINANCIAL NEWS: Agios raises $220M in upsized follow-on

    Agios Pharmaceuticals Inc. (NASDAQ:AGIO) raised $220 million through the sale of 2 million shares at $110.75 in an upsized follow-on underwritten by JPMorgan; Goldman Sachs; Cowen; and Leerink. The company had proposed …

    Published on 12/11/2014
  • FINANCIAL NEWS: Kite raises $188.2M in bumped-up follow-on

    Kite Pharma Inc. (NASDAQ:KITE) raised $188.2 million through the sale of 3.5 million shares at $54 in a bumped-up follow-on underwritten by Jefferies; Credit Suisse; Cowen; and Stifel. The company said Tuesday it …

    Published on 12/11/2014
  • FINANCIAL NEWS: Teva sees lower revenue, higher profit in 2015

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) introduced 2015 financial guidance on Thursday that projects net revenues below Street expectations but offers the prospect of better EPS due to cost cutting and product …

    Published on 12/11/2014
  • FINANCIAL NEWS: Genfit raises EUR 21M in private placement

    Genfit S.A. (Euronext:GNFT) raised EUR 21 million ($25.8 million) through the sale of 583,433 shares at EUR 35.95 in a private placement with institutional investors, including undisclosed U.S. investors. The price is a…

    Published on 12/10/2014
  • FINANCIAL NEWS: Versant closes new fund with $305M

    Versant Ventures closed its fifth fund with $305 million. It plans to invest Versant Venture Capital V in about 20-25 companies, with about three-quarters of those expected to be early stage biotech and the balance …

    Published on 12/10/2014
  • FINANCIAL NEWS: Agios seeks $175 million in follow-on

    Agios Pharmaceuticals Inc. (NASDAQ:AGIO) proposed to raise $175 million in a follow-on underwritten by JPMorgan; Goldman Sachs; Cowen; and Leerink. It proposed the offering after market close on Tuesday, having ended …

    Published on 12/9/2014
  • FINANCIAL NEWS: Bellicum sets IPO terms

    Bellicum Pharmaceuticals Inc. (Houston, Texas) set terms for its IPO on NASDAQ and now plans to sell 6.25 million shares at $15-$17. At $16, Bellicum would raise $100 million and be valued at $396.5 million. Jefferies; …

    Published on 12/9/2014
  • FINANCIAL NEWS: China's Adagene raises $8M in series A

    Adagene Inc. (Suzhou, China) raised $8 million in series A funding from Fidelity Biosciences; Fidelity Growth Partners Asia; and WuXi Venture Fund, the investment arm of Chinese CRO WuXi PharmaTech Inc. (NYSE:WX).…

    Published on 12/9/2014
  • FINANCIAL NEWS: Juno sets IPO terms, presents CAR T data

    Juno Therapeutics Inc. (Seattle, Wash.) set terms for its IPO on NASDAQ and now plans to sell 9.25 million shares at $15-$18. At $16.50, Juno would raise $152.6 million and be valued at $1.3 billion. The company filed …

    Published on 12/9/2014
  • FINANCIAL NEWS: Xoma raises $40M in follow-on

    Xoma Corp. (NASDAQ:XOMA) raised $40 million through the sale of 8 million units at $4.94 in a follow-on underwritten by Cowen. Each unit comprises one share and one two-year warrant to purchase one share exercisable at…

    Published on 12/9/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993